Blog

Notes on clinical development strategy, fundraising, and regulatory pathways for emerging biotech and pharma companies.

September 16, 2026

Welcome to the Nushev Biotech Advisory Blog

This is a placeholder post to show how the blog is structured — feel free to edit or delete it.

September 16, 2026

Why Do So Many Trials Miss First Patient In — Before Site Activation Even Begins?

After 20 years in clinical operations across the US, EU, UK, LatAm, APAC, CEE and the former USSR, I keep seeing the same pattern: a trial’s fate is usually ...

September 1, 2026

The Clinical Outsourcing Market Is Growing — But the Real Gap Remains

The clinical outsourcing market is growing fast — the global CRO market is on track to reach roughly $92B by 2030, and the FSP segment alone is projected to ...